Elizabeth Rubalcaba

617 total citations
8 papers, 517 citations indexed

About

Elizabeth Rubalcaba is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Elizabeth Rubalcaba has authored 8 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Oncology. Recurrent topics in Elizabeth Rubalcaba's work include Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cholesterol and Lipid Metabolism (1 paper). Elizabeth Rubalcaba is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cholesterol and Lipid Metabolism (1 paper). Elizabeth Rubalcaba collaborates with scholars based in United States. Elizabeth Rubalcaba's co-authors include Raphael P. Viscidi, Loren A. Zech, Frank T. Lindgren, Thomas J. Bronzert, H B Brewer, Roger Aamodt, Ernst J. Schaefer, Richard Daniel, Dana E. Rollison and Barbara Clayman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Journal of Lipid Research.

In The Last Decade

Elizabeth Rubalcaba

8 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Rubalcaba United States 8 164 149 148 134 92 8 517
Martijn Lindhout Netherlands 14 61 0.4× 47 0.3× 159 1.1× 317 2.4× 36 0.4× 24 806
Kyoji Moriya Japan 7 43 0.3× 70 0.5× 45 0.3× 230 1.7× 56 0.6× 12 953
Pierre-Marie Danzé France 16 136 0.8× 71 0.5× 96 0.6× 248 1.9× 17 0.2× 31 696
Agripina Suarez Canada 14 22 0.1× 203 1.4× 240 1.6× 413 3.1× 105 1.1× 20 964
Andrew B. Gerry United Kingdom 12 42 0.3× 279 1.9× 56 0.4× 160 1.2× 21 0.2× 25 637
Urbain Tchoua United States 10 112 0.7× 38 0.3× 180 1.2× 151 1.1× 49 0.5× 13 435
Katherine A. B. Knostman United States 12 80 0.5× 64 0.4× 26 0.2× 164 1.2× 35 0.4× 18 357
Masao Shinohara Japan 10 38 0.2× 10 0.1× 55 0.4× 110 0.8× 16 0.2× 25 465
Ángela Rojas Spain 14 78 0.5× 29 0.2× 73 0.5× 224 1.7× 148 1.6× 42 637
Jia Guo United States 15 79 0.5× 81 0.5× 35 0.2× 188 1.4× 53 0.6× 43 757

Countries citing papers authored by Elizabeth Rubalcaba

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Rubalcaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Rubalcaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Rubalcaba more than expected).

Fields of papers citing papers by Elizabeth Rubalcaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Rubalcaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Rubalcaba. The network helps show where Elizabeth Rubalcaba may publish in the future.

Co-authorship network of co-authors of Elizabeth Rubalcaba

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Rubalcaba. A scholar is included among the top collaborators of Elizabeth Rubalcaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Rubalcaba. Elizabeth Rubalcaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dickerson, Faith, Elizabeth Rubalcaba, Raphael P. Viscidi, et al.. (2008). Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia. Schizophrenia Research. 104(1-3). 121–126. 24 indexed citations
2.
Viscidi, Raphael P., Dana E. Rollison, Barbara Clayman, et al.. (2003). Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays. Clinical and Vaccine Immunology. 10(2). 278–285. 119 indexed citations
3.
Strunnikova, N., Stuart C. Ray, Robert A. Livingston, Elizabeth Rubalcaba, & Raphael P. Viscidi. (1995). Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression. Journal of Virology. 69(12). 7548–7558. 55 indexed citations
4.
Coutlée, François, Elizabeth Rubalcaba, Raphael P. Viscidi, et al.. (1990). Quantitative detection of messenger RNA by solution hybridization and enzyme immunoassay.. Journal of Biological Chemistry. 265(20). 11601–11604. 19 indexed citations
5.
Levine, Richard M., Elizabeth Rubalcaba, Marc E. Lippman, & Kenneth H. Cowan. (1985). Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line.. PubMed. 45(4). 1644–50. 25 indexed citations
6.
Schaefer, Ernst J., Loren A. Zech, Thomas J. Bronzert, et al.. (1982). Human apolipoprotein A-I and A-II metabolism. Journal of Lipid Research. 23(6). 850–862. 179 indexed citations
7.
Schaefer, Ernst J., D.W. Anderson, Loren A. Zech, et al.. (1981). Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.. Journal of Lipid Research. 22(2). 217–228. 61 indexed citations
8.
Stroshane, Ronald M., et al.. (1979). Isolation and structure elucidation of a novel griseorhodin.. The Journal of Antibiotics. 32(3). 197–204. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026